Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Inflammation damages sweat ducts, causing sweat gland injury.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

ILC1-like cells can independently cause alopecia areata.

The assay effectively identifies compounds that affect immune cell activation.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

Zinc may help treat alopecia areata by boosting certain immune cells.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

BTNL2 helps protect hair follicles from immune attacks.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Targeting specific T cells may help treat alopecia areata.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Blood count parameters are not reliable for predicting recurrent implantation failure.